Feng Wang
A GI oncologist whose work on immunotherapy biomarkers and Chinese gastric cancer trials feeds global guidelines.
Feng Wang leads gastrointestinal immunotherapy research at SYSUCC, including biomarker analyses for PD-1 response and Chinese trials of first-line immunochemotherapy in gastric cancer.
Pages like this
not linked directly; found by shared links- InstitutionFirst Affiliated Hospital of Sun Yat-sen University
Shares Sun Yat-sen University Cancer Center, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- InstitutionHunan Cancer Hospital
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer.
- InstitutionTaipei Veterans General Hospital
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer.
- InstitutionOlivia Newton-John Cancer Wellness and Research Centre
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors, Colorectal cancer.
- InstitutionHenan Cancer Hospital
Shares Gastric & gastro-oesophageal junction cancer, Immune checkpoint inhibitors.
- IdeaStructured mentorship so district general surgeons perform common cancer operations safely
Shares Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- PersonDavid Cunningham
Shares Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- PersonRui-Hua Xu
Shares Sun Yat-sen University Cancer Center, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.